Lauxera Capital Partners has acquired a €10 million majority stake in Matrix Requirements, a MedTech quality management software provider.
The software editor helps medical device companies meet their growing need for quality and regulatory compliance in a world where the lines between medical devices and software are blurring.
In addition to more traditional MedTech clients, Matrix’s product portfolio is designed to serve the fast-growing “software as a medical device” field encompassing digital therapeutics, connected devices, and technologies leveraging machine learning/artificial intelligence.
This is the seventh investment made by Lauxera Growth I, a growth and growth buy-out fund dedicated to investing in European HealthTech.
